Influence of Anti-Plasmodial Metal Complex on Rumen Microbial Populations and Serum Parameters in Sheep

A locally synthesized transition metal complex, cobalt-lumefantrine was assessed through laboratory and feeding trials to ascertain its usefulness as an agent for manipulation of the rumen in sheep grazing tropical pasture. The antimicrobial properties of the metal complex were examined on fresh rumen fluids at different concentrations (0, 0.010, 0.025 and 0.050 mg metal complex/50 ml) to estimate the optimum dosage for the sheep. Thereafter, twelve adult male sheep (11.27 \ub1 0.62 kg, initial body weight) were divided into three similar treatment groups. Sheep were drenched individually with 2.5 mg metal complex/head dissolved in 10 ml distilled water, either once or at two-week interval over 28 days. The control group received water without the metal complex. Total protozoa population was lowest (P < 0.05) when 50 ml rumen sample was incubated with 0.025 mg cobalt-lumefantrine metal complex. Serum alanine amino transferase, ALT (23.73 and 18.16 vs. 16.92 \ub5g/L) and cholesterol (0.94 and 1.18 vs. 1.40 mmol/L) levels were significantly (P < 0.05) influenced by the antiplasmodial metal complex treatments (single and repeated treatments vs. the control). It was concluded that 2.5 mg cobalt-lumefantrine complex treatment had no adverse effects on rumen pH, favourably modified rumen microbial populations and improved serum cholesterol level in the sheep

The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance

INTRODUCTION Investment in Africa over the past year with regard to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) sequencing has led to a massive increase in the number of sequences, which, to date, exceeds 100,000 sequences generated to track the pandemic on the continent. These sequences have profoundly affected how public health officials in Africa have navigated the COVID-19 pandemic. RATIONALE We demonstrate how the first 100,000 SARS-CoV-2 sequences from Africa have helped monitor the epidemic on the continent, how genomic surveillance expanded over the course of the pandemic, and how we adapted our sequencing methods to deal with an evolving virus. Finally, we also examine how viral lineages have spread across the continent in a phylogeographic framework to gain insights into the underlying temporal and spatial transmission dynamics for several variants of concern (VOCs). RESULTS Our results indicate that the number of countries in Africa that can sequence the virus within their own borders is growing and that this is coupled with a shorter turnaround time from the time of sampling to sequence submission. Ongoing evolution necessitated the continual updating of primer sets, and, as a result, eight primer sets were designed in tandem with viral evolution and used to ensure effective sequencing of the virus. The pandemic unfolded through multiple waves of infection that were each driven by distinct genetic lineages, with B.1-like ancestral strains associated with the first pandemic wave of infections in 2020. Successive waves on the continent were fueled by different VOCs, with Alpha and Beta cocirculating in distinct spatial patterns during the second wave and Delta and Omicron affecting the whole continent during the third and fourth waves, respectively. Phylogeographic reconstruction points toward distinct differences in viral importation and exportation patterns associated with the Alpha, Beta, Delta, and Omicron variants and subvariants, when considering both Africa versus the rest of the world and viral dissemination within the continent. Our epidemiological and phylogenetic inferences therefore underscore the heterogeneous nature of the pandemic on the continent and highlight key insights and challenges, for instance, recognizing the limitations of low testing proportions. We also highlight the early warning capacity that genomic surveillance in Africa has had for the rest of the world with the detection of new lineages and variants, the most recent being the characterization of various Omicron subvariants. CONCLUSION Sustained investment for diagnostics and genomic surveillance in Africa is needed as the virus continues to evolve. This is important not only to help combat SARS-CoV-2 on the continent but also because it can be used as a platform to help address the many emerging and reemerging infectious disease threats in Africa. In particular, capacity building for local sequencing within countries or within the continent should be prioritized because this is generally associated with shorter turnaround times, providing the most benefit to local public health authorities tasked with pandemic response and mitigation and allowing for the fastest reaction to localized outbreaks. These investments are crucial for pandemic preparedness and response and will serve the health of the continent well into the 21st century

Successful Use of Extracorporeal Membrane Oxygenation Postpartum as Rescue Therapy in a Woman With COVID-19

Clinical manifestations of coronavirus disease 2019 in pregnant women, in contrast to previous outbreaks, seem to be similar to those of nonpregnant women. During severe acute respiratory syndrome (SARS), SARS influenza A, and Middle East respiratory syndrome outbreaks, an increased severity of disease among pregnant women was observed. In some pregnant women, respiratory failure can occur and progress quickly to acute respiratory distress syndrome requiring extracorporeal membrane oxygenation (ECMO) as a rescue therapy. Despite a lack of current guidelines on the use of ECMO in pregnant or postpartum women, this support therapy is an effective salvage therapy for patients with cardiac and/or respiratory failure, and is associated with favorable maternal and fetal outcomes. Herein, the authors report a case of severe COVID-19 disease in a pregnant patient after urgent cesarean delivery, who was treated successfully with ECMO during the postpartum. Extracorporeal membrane oxygenation should be considered early when conventional therapy is ineffective, and it is essential to refer to ECMO expert centers

Phytochemical Screening, Antimicrobial and Antioxidant Activities of Aloe buettneri, Mitracarpus scaber and Hannoa undulata used in Togolese Cosmetopoeia

Background: Aloe buettneri, Mitracarpus scaber and Hannoa undulata are three plants species used in the Togolese traditional medicine to cure dermatosis. This study aims at assessing their anti-oxidant and anti-microbial activities on acne-developing micro-organisms. Methods: Six micro-organisms including Cutibacterium acnes ATCC 6919, Pseudomonas aeruginosa ATCC 27853; Escherichia coli ATCC 25922; Klebsiella pneumoniae ATCC 700603; Staphylococcus aureus ATCC 29213; and Candida albicans ATCC 35659 were used. Inhibition diameter was assessed using the agar well diffusion method. Minimum inhibitory and minimum microbicidal concentrations have been achieved through the liquid dilution method. Anti-oxidant activities were evaluated by DPPH antiradical scaving and FRAP methods. Phytochemical screening was also realized. Results: All the microorganism’s strains tested, excepted Candida albicans and Escherichia coli, were susceptible to plants extracts at 250 mg/mL in the agar well diffusion assay with inhibition diameters ranging from 12.10 ± 0.07 to 18.20 ± 0.10 mm. The MICs values were comprised between 15.625 mg/mL and 62.5 mg/mL, when MMCs ranged from 31.25 to 125 mg/mL. At the concentration of 500 µg/mL, the scavenging properties on DPPH radicals were 49.20 ± 0.15% for H. undulata, 41.29 ± 0.51% for A. buettneri, 59.57 ± 0.41% for M. scaber and 87.22 ± 0.03% for Quercetin. For FRAP assay, the effective concentration (EC50) of A. buettneri, M. scaber and H. undulata extracts were 977.44 ± 1.13 µg/mL; 267.74 ± 10.13 µg/mL and, 272.54 ± 12.87 µg/mL respectively while quercetin presented the EC50 of 48.63 ± 2.00 µg/mL. The antimicrobial and antioxidant activities of these species might be required to the presence of polyphenols, tannins, flavonoids, triterpenes, saponoside and alkaloids identified by phytochemical screening. Conclusion: The three plants extracts are all potential natural antimicrobial and antioxidant candidates for treating acne vulgaris. Keywords: Aloe buettneri, Mitracarpus scaber, Hannoa undulata, antimicrobial activity, antioxidant activity, phytochemical screening, Acne vulgari